Anti-tumour effects of transcatheter arterial embolisation administered in combination with thalidomide in a rabbit VX2 liver tumour model

By NITTA-SEKO A   NITTA N   SONODA A   OTANI H   Tsuchiya K   OHTA S   TAKAHASHI M   MURATA K  

British Journal of Radiology, Vol. 84, Iss. 998, 2011-02 ,pp. : 179-183

British Institute of Radiology

Access to resources Recommend Favorite

Staphylococcus aureus thymic abscesses associated with anti-tumour necrosis factor therapy

By Osiri M.   Tantawichien T.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 4, 2007-01 ,pp. : 320-321

Informa Healthcare

Access to resources Recommend Favorite

Retention of tocilizumab and anti-tumour necrosis factor drugs in the treatment of rheumatoid arthritis

By Hishitani Y   Ogata A   Shima Y   Hirano T   Ebina K   Kunugiza Y   Shi K   Narazaki M   Hagihara K   Tomita T   Yoshikawa H   Tanaka T   Kumanogoh A  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 4, 2013-08 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite

Anti-Cytokine Strategies beyond Anti-Tumour Necrosis Factor-α Therapy: Pathophysiology and Clinical Implications

By  

Digestive Diseases, Vol. 35, Iss. 1-2, 2017-02 ,pp. : 5-12

Karger

Access to resources Recommend Favorite

Electrolytic Treatment of Colorectal Liver Tumour Deposits in a Rat Model: A Technique with Potential for Patients with Unresectable Liver Tumours

By  

Digestive Diseases, Vol. 18, Iss. 2, 2000-10 ,pp. : 50-57

Karger

Access to resources Recommend Favorite